Why Peptide Blends Need Per-Component Assay

A single purity percentage printed on a two-peptide vial is not a meaningful number. Purity, as reported on a peptide Certificate of Analysis, is a ratio: the area of one chromatographic peak divided by the total area of everything the detector saw. That definition works when there is exactly one target. Put two target peptides in the same vial and the denominator no longer describes anything, because both peaks are supposed to be there. The correct analytical treatment is to quantify each component separately and report per-component assay masses — which is what a laboratory actually does, and what a supplier should actually publish.

For research use only — not for human or veterinary use.

How purity is calculated, and why blends break it

Reversed-phase HPLC purity for a single-component peptide is conventionally determined by area normalisation. The sample is separated on a C18 column under a gradient, ultraviolet absorbance is monitored at around 214–220 nm where the peptide bond absorbs, and the target peak's integrated area is expressed as a percentage of the total integrated area of all peaks. Everything that is not the target — deletion sequences, truncated fragments, incompletely deprotected species, oxidation products — sits in the denominator and reduces the figure.

Now add a second target peptide. The chromatogram has two large peaks that both belong there. Three things go wrong at once:

• There is no single target. Reporting the larger peak as "purity" silently redefines the second peptide as an impurity. Reporting the two peaks summed produces a number that says nothing about either component.
• Detector response is not equal. UV absorbance at 214 nm scales with the number of peptide bonds and the aromatic content of the sequence, so two peptides present in identical mass do not produce identical peak areas. Area percentage is not mass percentage across different molecules.
• The ratio is invisible. The property most researchers actually need from a blend — how much of each component is present — is precisely what a combined percentage discards.

A supplier publishing "99.4% purity" against a two-peptide vial has either tested only one of the two components and labelled the result as though it covered both, or has generated a figure that does not correspond to any defined quantity. Neither is a good sign, and the Certificate of Analysis library marks blend reports Assay only for exactly this reason rather than inventing a percentage.

What the laboratory does instead

For a multi-component vial the analytical question changes from "what fraction of this is the target" to "how much of each named analyte is present". That is a quantitative assay, run against reference material for each component, and it produces a mass figure per component rather than a percentage.

The published analytical literature treats these as separate quality attributes. A 2025 review in the Journal of Peptide Science on regulatory guidelines for peptide and protein analysis sets out identity confirmation (by mass spectrometry and sequencing), purity and impurity profiling (by chromatographic separation), and content or potency determination as distinct requirements with separate validation. Quantitative RP-HPLC of peptides without a fully pure reference sample has its own methodological literature going back decades, and the difficulty is well recognised.

The practical output is straightforward to read: for each named analyte, a measured mass, alongside that component's share of the label weight.

Two worked examples from published TXLABS reports

Both blends in the TXLABS catalogue that carry published certificates were quantified this way by Janoshik Analytical.

BPC-157 with TB-500

Batch CS-t/b55-0108, tested 16 January 2026, against a label weight of 5 mg + 5 mg:

• BPC-157 — 5.80 mg
• TB-500 (TB4) — 5.54 mg

Both components measure above their respective label weights. The measured ratio is approximately 1.05 : 1 rather than exactly 1 : 1. The product page for this material is BPC-157 5 mg + TB-500 5 mg.

CJC-1295 (mod GRF 1-29) with ipamorelin

Batch CS-c/i55-0228, tested 16 March 2026, against a label weight of 5 mg + 5 mg:

• CJC-1295 (mod GRF 1-29) — 6.61 mg
• Ipamorelin — 6.04 mg

Again both components exceed label weight, at a measured ratio of roughly 1.09 : 1. The product page is CJC-1295 no DAC 5 mg + ipamorelin 5 mg.

Note also what the analyte names carry. The second report names CJC-1295 (mod GRF 1-29) — the variant without the drug affinity complex — not "CJC-1295" unqualified. Those are different molecules with different molecular weights, and a certificate that names the wrong one is testing something other than what is in the vial.

What per-component assay actually tells you

• Whether each component is present at all. This is the failure mode a combined figure cannot detect: a blend containing a full complement of the cheaper peptide and a token quantity of the expensive one would still produce a respectable-looking single percentage.
• The actual ratio, not the nominal one. A 1 : 1 label describes intent. Only two measured masses describe the vial. For any work where the ratio between components is a controlled variable, the nominal figure is not usable.
• The correct input for reconstitution arithmetic. Concentration is mass divided by diluent volume, per component. With a blend, that is two concentrations from one vial, and both derive from measured masses. The reconstitution calculator handles the arithmetic once you know which masses to enter.
• Batch specificity. These figures describe one lot. Two batches of nominally identical blend can differ in both absolute mass and ratio, which is why a certificate that does not name a batch number and test date is not doing its job.

Reading a blend certificate

A defensible report on a multi-component vial should show, at minimum: each analyte named in full including variant, a measured mass for each, the label weight it is being compared against, a batch number, a test date, and the name of the laboratory that performed the work. Where identity is confirmed, mass spectrometry data for each component belongs there too — quantifying a peak is only meaningful if the peak has been identified.

What should not be there is a single purity percentage standing in for all of it. Blend chemistry is a place where the shortcut and the correct answer look superficially similar on a product page, and where the correct answer is more informative in every respect. Research-grade blends and single-component recovery peptides are listed in the recovery category, and the published reports for both blends above are in the Certificate of Analysis library.

For research use only. Products supplied by TXLABS are laboratory research chemicals intended for in-vitro and laboratory research by qualified professionals. They are not medicines, supplements, foods or cosmetics, and are not for human or veterinary use.